Abstract
The advent of transcriptome-wide association studies (TWAS) has expanded the classical genome-wide association study (GWAS) framework by integrating gene expression with genetic variation to identify trait-associated variants. While multi-tissue TWAS approaches improve statistical power over single-tissue models, existing methods often lose information during result aggregation and require intensive computation. Here, we present TWAS-CTL (Cross-Tissue Learner), a novel framework that leverages heterogeneous gene expression across tissues by adaptively reweighting and optimizing multiple single-tissue learners. Simulations demonstrate that TWAS-CTL achieves higher statistical power than the leading method, UTMOST, while maintaining proper type I error control and reducing computational time by over half. When applied to the analysis of the Genetics of Kidneys in Diabetes (GoKinD) cohort, we observed that TWAS-CTL identified more susceptible genes associated with diabetes than both UTMOST and PrediXcan, another widely used method in TWAS. These results establish TWAS-CTL as a powerful and efficient tool for cross-tissue gene expression analysis, capable of integrating heterogeneous gene-trait associations to advance genetic discovery.
Full text
1,647 characters
· extracted from
oa-doi-fallback
· click to expand
Abstract
The advent of transcriptome-wide association studies (TWAS) has expanded the classical genome-wide association study (GWAS) framework by integrating gene expression with genetic variation to identify trait-associated variants. While multi-tissue TWAS approaches improve statistical power over single-tissue models, existing methods often lose information during result aggregation and require intensive computation. Here, we present TWAS-CTL (Cross-Tissue Learner), a novel framework that leverages heterogeneous gene expression across tissues by adaptively reweighting and optimizing multiple single-tissue learners. Simulations demonstrate that TWAS-CTL achieves higher statistical power than the leading method, UTMOST, while maintaining proper type I error control and reducing computational time by over half. When applied to the analysis of the Genetics of Kidneys in Diabetes (GoKinD) cohort, we observed that TWAS-CTL identified more susceptible genes associated with diabetes than both UTMOST and PrediXcan, another widely used method in TWAS. These results establish TWAS-CTL as a powerful and efficient tool for cross-tissue gene expression analysis, capable of integrating heterogeneous gene-trait associations to advance genetic discovery.
Competing Interest Statement
The authors have declared no competing interest.
Footnotes
Changes from previous version- fixed typos, further refined all the sections (Introduction, Methods, Results, Discussion), etc.
https://www.ncbi.nlm.nih.gov/projects/gap/cgi-bin/study.cgi?study_id=phs000424.v8.p2
https://www.ncbi.nlm.nih.gov/projects/gap/cgi-bin/study.cgi?study_id=phs000018.v2.p1
Text is read by the "Ask this paper" AI Q&A widget below.
Extraction quality varies by source — PMC NXML preserves structure
cleanly, OA-HTML may include some navigation residue, and OA-PDF can
have broken hyphenation. The publisher copy
(via DOI)
is the canonical version.